KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and …
T Zhang, P Shen, C Duan, L Gao - Frontiers in Immunology, 2021 - frontiersin.org
Object Interstitial lung disease (ILD) is a specific form of chronic fibrosing interstitial
pneumonia with various etiology. The severity and progression of ILD usually predict the …
pneumonia with various etiology. The severity and progression of ILD usually predict the …
Acute exacerbations of fibrotic interstitial lung diseases
A Suzuki, Y Kondoh, KK Brown, T Johkoh… - …, 2020 - Wiley Online Library
Background and objective Acute exacerbation (AE) is a severe complication of idiopathic
pulmonary fibrosis (AE‐IPF). In 2016, an international working group revised its definition …
pulmonary fibrosis (AE‐IPF). In 2016, an international working group revised its definition …
Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
H Kamiya, OM Panlaqui - BMJ open, 2020 - bmjopen.bmj.com
Objective To clarify prognostic factors of acute exacerbation (AE) of idiopathic pulmonary
fibrosis (IPF). Design A systematic review and meta-analysis. Data sources Medline …
fibrosis (IPF). Design A systematic review and meta-analysis. Data sources Medline …
Circulatory serum Krebs von den Lungen-6 and surfactant protein-D concentrations predict interstitial lung disease progression and mortality
There is a need for biomarkers to predict outcomes, including mortality, in interstitial lung
disease (ILD). Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) are …
disease (ILD). Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) are …
[HTML][HTML] Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease
M Kono, K Miyashita, R Hirama, Y Oshima, K Takeda… - Respiratory …, 2021 - Elsevier
Background Acute exacerbation (AE) of interstitial lung disease (ILD) is an acute respiratory
deterioration of unknown etiology, associated with high mortality. Currently, bronchoalveolar …
deterioration of unknown etiology, associated with high mortality. Currently, bronchoalveolar …
[HTML][HTML] Alleviation of inflammatory response of pulmonary fibrosis in acute respiratory distress syndrome by puerarin via transforming growth factor (TGF-β1)
X Hu, X Huang - … science monitor: international medical journal of …, 2019 - ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) in infants is acute and progressive
hypoxic respiratory failure caused by various extrapulmonary pathogenic factors besides …
hypoxic respiratory failure caused by various extrapulmonary pathogenic factors besides …
High‐dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias
T Arai, K Tachibana, C Sugimoto, Y Inoue… - …, 2017 - Wiley Online Library
Background and objective Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF)(AE‐
IPF) is a poor prognostic disorder. AE is also reported to occur in other idiopathic interstitial …
IPF) is a poor prognostic disorder. AE is also reported to occur in other idiopathic interstitial …
Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
T Suzuki, H Hozumi, K Miyashita, M Kono, Y Suzuki… - Scientific Reports, 2021 - nature.com
Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is a major prognostic
determinant. However, evidence for its prognostic strength is mainly based on the results of …
determinant. However, evidence for its prognostic strength is mainly based on the results of …
Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Background Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) increases
mortality risk, but which factors increase mortality is unknown. We aimed to perform a …
mortality risk, but which factors increase mortality is unknown. We aimed to perform a …
[HTML][HTML] Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation
SP Keller - Annals of Cardiothoracic Surgery, 2020 - ncbi.nlm.nih.gov
The introduction of the lung allocation score in 2005 prioritized patients with decreased
transplant-free survival as the recipients of donor organs and effectively increased the …
transplant-free survival as the recipients of donor organs and effectively increased the …